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Abstract
Apolipoprotein-D is a glycosylated tetrameric lipocalin that binds and transports small hydrophobic
molecules such as progesterone and arachidonic acid. Like other lipocalins, apolipoprotein-D adopts an eight-
stranded β-barrel fold stabilized by two intramolecular disulphide bonds, with an adjacent α-helix.
Crystallography studies of recombinant apolipoprotein-D demonstrated no major conformational changes
upon progesterone binding. Amide hydrogen-deuterium exchange mass spectrometry (HDX-MS) reports
structural changes of proteins in solution by monitoring exchange of amide hydrogens in the protein
backbone with deuterium. HDX-MS detects changes in conformation and structural dynamics in response to
protein function such as ligand binding that may go undetected in X-ray crystallography, making HDX-MS an
invaluable orthogonal technique. Here, we report an HDX-MS protocol for apolipoprotein-D that solved
challenges of high protein rigidity and low pepsin cleavage using rigorous quenching conditions and longer
deuteration times, yielding 85% sequence coverage and 50% deuterium exchange. The relative fractional
deuterium exchange of ligand-free apolipoprotein-D revealed apolipoprotein-D to be a highly structured
protein. Progesterone binding was detected by significant reduction in deuterium exchange in eight peptides.
Stabilization of apolipoprotein-D dynamics can be interpreted as a combined orthosteric effect in the ligand
binding pocket and allosteric effect at the N-terminus and C-terminus. Together, our experiments provide
insight into apolipoprotein-D structural dynamics and map the effects of progesterone binding that are relayed
to distal parts of the protein. The observed stabilization of apolipoprotein-D dynamics upon progesterone
binding demonstrates a common behaviour in the lipocalin family and may have implications for interactions
of apolipoprotein-D with receptors or lipoprotein particles. Statement: We reveal for the first time how
apolipoprotein-D, which is protective in Alzheimer's disease, becomes more ordered when bound to a
molecule of steroid hormone. These results significantly extend the understanding of apolipoprotein-D
structure from X-ray crystallography studies by incorporating information on how protein motion changes
over time. To achieve these results an improved protocol was developed, suitable for proteins similar to
apolipoprotein-D, to elucidate how proteins change flexibility when binding to small molecules.
Publication Details
Kielkopf, C. S., Ghosh, M., Anand, G. & Brown, S. H.J. (2019). HDX-MS reveals orthosteric and allosteric
changes in apolipoprotein-D structural dynamics upon binding of progesterone. Protein Science, 28 (2),
365-374.
This journal article is available at Research Online: https://ro.uow.edu.au/smhpapers1/458
1 
 
HDX-MS reveals orthosteric and allosteric changes in apolipoprotein-D 1 
structural dynamics upon binding of progesterone 2 
Claudia S. Kielkopf1,2,3, Madhubrata Ghosh4†, Ganesh S. Anand4, Simon H.J. 3 
Brown1,2,3* 4 
1Illawarra Health and Medical Research Institute, University of Wollongong, 5 
Wollongong, NSW, Australia; 2Molecular Horizons, University of Wollongong, 6 
Wollongong, NSW, Australia; 3School of Biological Sciences, University of 7 
Wollongong, Wollongong, NSW, Australia; 4Department of Biological Sciences, 8 
National University of Singapore, Singapore. 9 
†Present address: Institute of Bioengineering and Nanotechnology, Singapore 10 
*To whom correspondence should be addressed: Simon H.J. Brown: Illawarra Health 11 
and Medical Research Institute, Room 230, Building 32, Northfields Ave, University 12 
of Wollongong, NSW 2522, AUSTRALIA; simonb@uow.edu.au; T:  + 61 2 4298 13 
1991; F:  + 61 2 4221 8130 14 
 15 
Running title: Apolipoprotein-D protein structural dynamics changes upon 16 








Total number of manuscript pages 24 
Total number of supplementary material pages 1 
Total number of tables 0 
Total number of figures 5 
Description of supplementary material  
including filenames 




Abstract  24 
Apolipoprotein-D is a glycosylated tetrameric lipocalin that binds and transports small 25 
hydrophobic molecules such as progesterone and arachidonic acid. Like other 26 
lipocalins, apolipoprotein-D adopts an eight-stranded β-barrel fold stabilised by two 27 
intramolecular disulphide bonds, with an adjacent α-helix. Crystallography studies of 28 
recombinant apolipoprotein-D demonstrated no major conformational changes upon 29 
progesterone binding.  30 
Amide hydrogen-deuterium exchange mass spectrometry (HDX-MS) reports 31 
structural changes of proteins in solution by monitoring exchange of amide 32 
hydrogens in the protein backbone with deuterium. HDX-MS detects changes in 33 
conformation and structural dynamics in response to protein function such as ligand 34 
binding that may go undetected in X-ray crystallography, making HDX-MS an 35 
invaluable orthogonal technique. 36 
Here, we report an HDX-MS protocol for apolipoprotein-D that solved challenges of 37 
high protein rigidity and low pepsin cleavage using rigorous quenching conditions 38 
and longer deuteration times, yielding 85% sequence coverage and 50% deuterium 39 
exchange. The relative fractional deuterium exchange of ligand-free apolipoprotein-D 40 
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revealed apolipoprotein-D to be a highly structured protein. Progesterone binding 41 
was detected by significant reduction in deuterium exchange in eight peptides. 42 
Stabilisation of apolipoprotein-D dynamics can be interpreted as a combined 43 
orthosteric effect in the ligand binding pocket and allosteric effect at the N- and C-44 
termini.  45 
Together, our experiments provide insight into apolipoprotein-D structural dynamics 46 
and map the effects of progesterone binding that are relayed to distal parts of the 47 
protein. The observed stabilisation of apolipoprotein-D dynamics upon progesterone 48 
binding demonstrates a common behaviour in the lipocalin family and may have 49 
implications for interactions of apolipoprotein-D with receptors or lipoprotein particles. 50 
 51 
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 55 
50-75-word statement  56 
We reveal for the first time how apolipoprotein-D, which is protective in Alzheimer’s 57 
disease, becomes more ordered when bound to a molecule of steroid hormone. 58 
These results significantly extend the understanding of apolipoprotein-D structure 59 
from X-ray crystallography studies by incorporating information on how protein 60 
motion changes over time. To achieve these results an improved protocol was 61 
developed, suitable for proteins similar to apolipoprotein-D, to elucidate how proteins 62 





AGP: α1-acid glycoprotein; apoD: apolipoprotein-D; BCF: breast cyst fluid; GuHCl: 66 
Guanidine hydrochloride; HDX-MS: amide hydrogen-deuterium exchange mass 67 
spectrometry; LC-MS: Liquid chromatography-mass spectrometry; SDS: sodium 68 
dodecyl sulphate; TCEP: Tris(2-carboxyethyl)phosphine hydrochloride. 69 
 70 
Introduction 71 
Apolipoprotein-D (apoD) is a glycosylated member of the lipocalin family and 72 
functions as lipid transporter and antioxidant. As a lipocalin, apoD folds into an eight-73 
stranded β-barrel with an adjacent α-helix as shown by X-ray crystallography (PDB 74 
ID 2hzr)1 and forms a tetramer when not associated with lipoprotein particles.2 Two 75 
intramolecular disulphide bonds stabilise the apoD structure and post-translational 76 
modifications include two N-linked glycosylations (Asn-45 and Asn-78, marked 77 
orange in Figure 1) and a pyroglutamate (Q-1).3,4 Via a conserved methionine 78 
residue (Met-93, marked blue in Figure 1), apoD can reduce peroxidised lipids.5 This 79 
antioxidant function apoD has been demonstrated in post-mortem human 80 
Alzheimer’s disease (AD) brain.6 ApoD contains three large hydrophobic loops at the 81 
entrance of the ligand binding pocket that are thought to facilitate binding to ligands, 82 
membranes and lipoprotein particles.1,7 In the pre-formed β-barrel ligand binding 83 
pocket, apoD specifically binds the small hydrophobic molecules progesterone and 84 
arachidonic acid with high affinity.8 Retinoic acid and certain fatty acids bind to apoD 85 
with lower affinity.9 X-ray crystallography structures at a resolution of 1.8 Å (PDB ID 86 
2hzq)1 have shown that progesterone is stacked in the ligand binding pocket by two 87 
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aromatic residues, Phe-89 and Trp-127. Three tyrosine residues, Tyr-22, Tyr-46 and 88 
Tyr-98, build a hydrogen bond network with progesterone. Interestingly, comparison 89 
of the crystal structures of ligand-free and progesterone-bound apoD showed that the 90 
binding pocket does not undergo major conformational changes upon progesterone 91 
binding.1 The root mean square deviation of the protein backbone in the ligand-free 92 
and progesterone-bound state was 0.38 Å and only three amino acid side chains 93 
(Asn-45, Asn-58 and Tyr-46) showed conformational changes.  94 
X-ray crystallography provides high resolution snapshots of conformational end 95 
states of proteins. However, these snapshots represent states under non-native 96 
crystallisation conditions and consequently do not offer complete insights into protein 97 
function in solution. Amide hydrogen-deuterium exchange mass spectrometry (HDX-98 
MS), in contrast, allows the monitoring of conformational fluidity and structural 99 
dynamics of proteins in solution, using the exchange of backbone amide hydrogens 100 
to deuterons as conformational probes.10 Following deuterium exchange and 101 
proteolysis by pepsin protease, liquid chromatography coupled to mass spectrometry 102 
(LC-MS) localises and quantifies the deuterium exchange in pepsin-cleaved 103 
peptides.10-12 The rate of deuterium exchange at a certain pH and temperature 104 
largely depends on hydrogen bond propensities and to a lesser degree solvent 105 
accessibility across the protein.13,14 Protection from deuterium exchange is due to 106 
amide hydrogens engaging in stable intramolecular hydrogen bond networks, which 107 
slows their exchange to deuterium. Therefore, a folded protein shows slower 108 
deuterium exchange than chemically possible, even if all amide hydrogens are 109 
solvent exposed. Thus, deuterium exchange can reflect changes in conformation and 110 
in structural dynamics of proteins as a result of interaction with binding partners. In 111 
conjunction with X-ray crystallographic structures, HDX-MS provides insights into the 112 
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dynamics of the protein in solution. This can be easily extended to map binding sites 113 
of ligands and identify orthosteric and allosteric sites.15  Communication between 114 
orthosteric and allosteric sites via hydrogen bond networks can then be inferred.16 115 
These aspects make HDX-MS an invaluable tool in a biochemist’s toolbox.  116 
Here, we analysed the deuterium exchange of ligand-free, tetrameric apoD, purified 117 
from human breast cyst fluid (BCF). This enabled the characterisation of structural 118 
features of native apoD using non-recombinant protein in solution. We next 119 
compared the deuterium exchange of ligand-free apoD with apoD bound to 120 
progesterone, an established ligand of apoD. In order to analyse apoD by HDX-MS, 121 
we established an HDX-MS protocol for apoD which increased the extent of pepsin 122 
cleavage, improved sequence coverage and enhanced deuterium exchange. This 123 
protocol is likely to be of use for other lipocalin family members and generally for 124 
heavily glycosylated proteins with rigid structures. Our results add to our 125 
understanding of native apoD structure and dynamics beyond what static crystal 126 
structures reveal. Furthermore, apoD structural dynamics may also be exemplary for 127 
common structural processes upon ligand binding within the lipocalin family. 128 
 129 
Results and Discussion 130 
Initial deuteration results using native tetrameric glycosylated apoD, purified from 131 
human BCF, showed that apoD was resistant to pepsin proteolysis and thus 132 
exhibited only limited proteolytic cleavage by pepsin following deuterium exchange, 133 
resulting in low sequence coverage of initially ~60% (data not shown). Optimising 134 
conditions for quenching deuterium exchange through addition of the chaotrope 135 
guanidine hydrochloride (GuHCl) and the reducing agent Tris(2-136 
carboxyethyl)phosphine hydrochloride (TCEP) as well as increasing the duration of 137 
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pepsin proteolysis to 7 minutes improved sequence coverage to 85% of the mature 138 
apoD sequence (Figure 1). Due to heterogeneous glycosylation, deuterium exchange 139 
of glycosylated apoD peptides (i.e. peptides including Asn-45 and Asn-78) was not 140 
quantified. Furthermore, we initially observed low deuterium exchange of apoD 141 
during a 10 min time-course at room temperature (data not shown), suggesting a 142 
highly rigid structure. We therefore increased the deuteration time-course to 120 min 143 
and increased the temperature to 37°C to identify additional reporter amides. This 144 
allowed us to monitor differences in deuterium exchange between ligand-free and 145 
ligand-bound apoD.  146 
Two other lipocalin family members have previously been studied with HDX-MS, β-147 
lactoglobulin17 and α1-acid glycoprotein (AGP).18 β-lactoglobulin, a homodimer19, 148 
showed little cleavage by pepsin, leading to low sequence coverage.17 In the case of 149 
AGP, a monomer 20, quenching conditions comparable to this study were used.18 150 
Both proteins contain disulphide bonds21, as do many other lipocalins20 including 151 
apoD.22 Therefore, our changes to the HDX-MS protocol are likely to be applicable 152 
across the lipocalin family and, more broadly, for proteins with inherently rigid 153 
structures and intra-subunit disulphide bonds. 154 
 155 
ApoD is a highly structured protein with high protection from deuterium exchange 156 
To gain insights into the dynamics of ligand-free apoD, the relative fractional 157 
exchange per peptide was calculated by dividing the absolute deuterium uptake by 158 
the number of exchangeable backbone amides for each peptide and time point 159 
(Figure 2A). Relative fractional uptake allows comparison of deuterium exchange of 160 
peptides of differing length across a protein sequence as the uptake is normalised to 161 
the number of exchangeable hydrogens. Overall, apoD showed a maximum relative 162 
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fractional exchange of 52%, out of a maximal 90% deuterium exchange and without 163 
back exchange correction. The low relative exchange points to a stable lipocalin fold 164 
of apoD, consisting of an eight-stranded β-barrel and an adjacent α-helix without any 165 
disordered segments (Figure 1, indicated by yellow arrows and red coils above the 166 
primary sequence). Additionally, protein glycosylation has been shown to confer a 167 
stabilising effect on protein structure, reflected in reduced dynamics at and around 168 
the glycosylation site.23 Therefore, it is likely that the extensive glycosylation of apoD 169 
reduces the structural dynamics of apoD leading to low deuterium exchange.23 170 
Interestingly, peptides 4-26, 93-124, 130-143, 130-147, 130-151, 130-169, 144-169 171 
and 152-169 (marked with asterisks, Figure 2A) showed characteristic bimodal 172 
exchange at the three time points examined. Bimodal exchange reflects ensemble 173 
behaviour and the existence of at least two slowly interchanging conformations in 174 
solution.24 This behaviour is exemplarily showed for peptide 130-169 in 175 
supplementary Figure S1. 176 
In some areas with overlapping peptides, the relative fractional uptake of overlapping 177 
peptides seemingly do not match (for instance peptide 86-92 with higher relative 178 
fractional uptake and 86-101 with lower relative fractional uptake). This can be 179 
explained by differences in the number of exchangeable amide hydrogens. The 180 
absolute uptake for peptide 86-92 (3.4 Da after 120 min) is lower than for peptide 86-181 
101 (4.3 Da after 120 min) but due to the different number of exchangeable 182 
hydrogens (6 vs 13), the relative fractional uptake is higher for peptide 86-92 than for 183 
peptide 86-101.  184 
We observed low relative deuterium exchange in peptide 102-111 (blue) and high 185 
deuterium exchange in peptide 130-143 (orange) (Figure 2A). For both peptides, the 186 
absolute deuterium exchange over time and the mass spectra for undeuterated, 10 187 
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min deuteration and 120 min deuteration are shown in Figure 2B and C. Mapping the 188 
peptides onto the apoD crystal structure (Figure 2E) showed that the peptide 102-189 
111 (blue, exhibiting low exchange) is part of the β-barrel and encompasses a short 190 
hairpin loop. It is likely that this part of apoD is in a rigid conformation with stable 191 
backbone hydrogen bonds maintaining the structure in a predominantly closed state 192 
and therefore remains unavailable for deuterium exchange. In contrast, peptide 130-193 
143 (orange, exhibiting high exchange) is situated in a larger loop and includes part 194 
of the adjacent α-helix. The high deuterium exchange in this peptide is indicative of a 195 
less structured part of apoD. The difference in deuterium exchange behaviour 196 
between the peptides 102-111 and 130-143 corresponds to the difference in b-197 
factors observed in the crystal structure for these regions1. Peptide 102-111 has an 198 
average b-factor of 16.9 Å2, compared to 22.0 Å2 for peptide 130-143.  199 
We additionally observed differences in dynamics over the time course between the 200 
peptides 102-111 and 49-61 (blue and green, Figure 2B and D). Peptide 102-111 201 
(blue, Figure 2B) showed almost no changes in deuteration over the deuteration time 202 
course. As described above, peptide 102-111 encompasses β-strands and a short 203 
hairpin loop (Figure 2E), a highly structured region with low structural dynamics. In 204 
contrast, the deuterium exchange of peptide 49-61 (green, Figure 2D) increased over 205 
the time frame of the experiment, indicating high dynamics. The peptide 49-61 206 
(green, Figure 2E) is part of the β-barrel and encompasses a turn at the closed end 207 
of the barrel and a complete β-strand running from the back to the front of the ligand 208 
pocket. Increasing exchange over the time-course in this protein area indicates 209 
higher dynamics with a transition of the protein from a closed to a transient 210 
exchangeable state within the timescale of our experiment.25  211 
10 
 
To gain differential insights into the overall deuteration behaviour of apoD, we 212 
generated a heat map to visually assess the deuterium exchange across the apoD 213 
sequence (Figure 1). The relative fractional deuterium exchange after 120 min of 214 
each peptide was colour-coded from 0% to a maximum exchange of 52%. In 215 
addition, nine non-overlapping peptides covering 83% of apoD were selected and the 216 
relative fractional deuterium exchange after 120 min was mapped onto the crystal 217 
structure of apoD. These results are displayed by colour-coding and cartoon ‘putty’ 218 
representation (Figure 3A). In the putty style, the diameter of the tubular spine 219 
representing the protein backbone is proportional to the relative fractional deuterium 220 
exchange. Regions in which no peptides were detected were set to blue and appear 221 
thinnest in the putty representation. This analysis showed that the overall relative 222 
fractional exchange of apoD was divided. The N-terminus with the short 310-helix and 223 
the first three β-strands showed relatively low deuterium exchange indicating 224 
structural protection from deuterium exchange. The glycosylations can contribute to 225 
low exchange due to reducing structural dynamics in these areas.23 Additionally, the 226 
observed low deuterium exchange in the first three β-strands indicates that the 227 
modelled tetramer inter-subunit interface in this area is stable and consequently, 228 
resistant to deuterium exchange.2 229 
In contrast, the C-terminal α-helix and disordered region showed relatively high 230 
deuterium exchange which indicates lower structural protection. The high exchange 231 
in this area can also point towards a more fluid inter-subunit interface within the apoD 232 
tetramer.2  233 
 234 
We next identified three overall regions with high (areas 1 and 3) and low dynamics 235 
(area 2), marked in Figure 2A. These areas were then mapped onto the crystal 236 
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structure in green (area 1: 4-61, area 3: 128-169) and magenta (area 2: 62-127), 237 
respectively (Figure 3B). It appeared that the N- and C-termini (green) both display 238 
high structural dynamics. The area with low structural dynamics (magenta) tended to 239 
cover mostly the β-barrel ligand binding pocket which indicates the more stably 240 
folded core of apo D. 241 
 242 
Progesterone binding induces stabilisation of the apoD ligand binding pocket 243 
To characterise effects of progesterone binding on apoD, we pre-incubated apoD 244 
with progesterone, performed HDX-MS and compared the deuterium exchange of the 245 
progesterone-bound with the ligand-free form of apoD. A difference plot (Figure 4A) 246 
shows the differences in deuterium exchange in all detected peptides. Considering a 247 
difference in absolute deuterium uptake of > ±0.5 Da for at least one time point as 248 
significant, differences were observed in nine peptides. Out of these nine peptides, 249 
eight peptides showed reduced deuterium exchange in the progesterone-bound form 250 
of apoD over the entire time-course of the experiment (10-120 min). Peptide 49-61, in 251 
contrast, showed increased deuterium exchange upon progesterone binding. The 252 
absolute deuterium exchange graphs for all nine peptides are shown in Figure 2B.  253 
 254 
According to Konerman et al.26, ligand binding can cause three different HDX 255 
scenarios: In a type 0 scenario, ligand binding causes no effect on deuterium 256 
exchange. In a type 1 scenario, ligand binding causes a strengthening of 257 
intramolecular hydrogen bonding, leading to decreased deuterium exchange. In a 258 
type 2 scenario, ligand binding causes a weakening of intramolecular hydrogen 259 
bonding, leading to increased deuterium exchange. In the case of apoD, deuterium 260 
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exchange upon progesterone binding shows both type 1 and 2 scenarios, illustrating 261 
a mixed deuterium exchange response and differential free energy shifts, in different 262 
parts of the protein. 263 
 264 
Mapping the differences in deuterium exchange onto the crystal structure revealed 265 
that changes take place in the ligand binding pocket upon progesterone binding 266 
(Figure 4C). The peptides 86-101 and 93-124, which show decreased deuterium 267 
exchange, encompass four β-strands with two large hydrophobic turns indicating a 268 
stabilisation upon progesterone binding (blue surface representation). In contrast, 269 
peptide 49-61, which comprises one β-strand within the binding pocket, showed 270 
increased deuterium exchange suggesting a destabilisation upon progesterone 271 
binding (red surface representation). When comparing the average B-factors of the 272 
apoD crystal structure in the region of peptide 49-61, the average B-factor in the 273 
progesterone-bound structure (25.7 Å2) is higher than in the apo-form structure (24.6 274 
Å2)1 which supports our observation of a destabilisation. Interestingly, in peptide 49-275 
61, the difference in hydrogen exchange between the apo-form and progesterone-276 
bound apoD diminishes over the course of the experiment. ApoD in the apo-form 277 
initially has a lower exchange at 10 min but the slope of the exchange curve over 278 
time is steeper than in the progesterone-bound form. Therefore, the deuterium 279 
exchange converges with time over the experiment. This behaviour can be 280 
interpreted as a weakening of hydrogen bonds upon progesterone binding.  281 
Closer examination of the changes within the ligand binding pocket indicates two 282 
crucial first-shell amino acids of apoD that make contact with progesterone are 283 
located in the stabilised regions: Phe-89 and Tyr-98 (Figure 4D). Phe-89, together 284 
with Trp-127, sandwiches progesterone in the ligand binding pocket.1 The Tyr-98 285 
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sidechain is involved in a hydrogen bond network with progesterone, Tyr-22 and Tyr-286 
46.1 Our data indicate that Phe-89 and Tyr-98 are responsible for conveying the 287 
binding of progesterone to stabilisation of the protein backbone. No coverage was 288 
obtained for Tyr-46. Peptide 49-61, which showed increased deuterium exchange 289 
upon progesterone binding, encompasses Asn-58. In ligand-free apoD, Asn-58 forms 290 
a hydrogen bond with Tyr-46 via a water molecule. Upon progesterone binding, 291 
however, this hydrogen bond breaks due to rotation of the Asn-58 side chain.1 The 292 
breakage of a hydrogen bond and the accompanying conformational change may 293 
cause the destabilisation of the protein backbone, resulting in an increase in 294 
deuterium exchange.  295 
Remarkably, other important features of apoD are located within the stabilised 296 
regions (Figure 4C and D). Two of the large hydrophobic turns in the stabilised area 297 
at the entry of the apoD ligand binding pocket are hypothesised to be involved in 298 
binding to membranes and lipoprotein particles as well as in facilitating the exchange 299 
and release of ligands.1,7 In addition, the redox-active Met-935 is located in this 300 
stabilised area. Therefore, stabilisation of apoD in this area could modify these 301 
aspects of apoD function. 302 
 303 
Allosteric effects of apoD upon progesterone binding 304 
Differences in apoD deuterium exchange were not only observed orthosterically in 305 
the ligand binding pocket but also allosterically in distal parts of the protein. The N-306 
terminal peptide 4-26 and a large C-terminal part of apoD (peptides covering amino 307 
acids 126-169) showed reduced deuterium exchange, indicating a stabilising effect, 308 
upon binding of progesterone (Figure 4E and F). The allosteric changes of structural 309 
dynamics in the N-terminal peptide may be conveyed through Tyr-22 in the second 310 
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shell. Tyr-22 is in a hydrogen bond network with Tyr-46 which in turn forms the direct 311 
hydrogen bond with progesterone and Tyr-98.1 Furthermore, a disulphide bond 312 
connects Cys-114 in the β-barrel pocket to the N-terminal Cys-8. This covalent 313 
connection may allow allosteric communication of protein stabilisation. Intriguingly, 314 
the N-terminal peptide includes the 310-helix at the bottom of the apoD ligand binding 315 
pocket which is thought to be involved in binding of apoD to its potential receptor 316 
basigin.27 It is therefore possible that the observed allosteric changes in this area 317 
have implications for apoD function. Stabilisation of this area upon ligand binding 318 
could enhance recognition and binding to basigin and therefore facilitate uptake of 319 
ligand-bound apoD into a cell. 320 
The communication of structural changes from the ligand binding pocket to the C-321 
terminus may be transmitted by hydrophobic contacts between the ligand pocket and 322 
the α-helix in the C-terminus and via a cluster of hydrogen bonds between Tyr-22 323 
and Arg-131 (Figure 4F).  324 
It is noteworthy that the peptides in the C-terminal region exhibited a large absolute 325 
change in deuterium exchange upon binding of progesterone. A large number of 326 
peptides in the N and C-termini of apoD showed characteristic bimodal envelope 327 
profiles upon deuterium exchange at the time points examined (Figure S1). The two 328 
envelopes reflect a lower exchanging conformation in equilibrium with a greater 329 
exchange conformation in slow timescales (milliseconds and slower) in solution. 330 
Progesterone binding increased the relative abundance of the lower exchanging 331 
conformation and overall shifted the centroid lower upon progesterone binding. The 332 
presence of bimodal exchange is characteristic of EX1 deuterium exchange kinetics 333 
28 and explains how ligand (progesterone) binding promotes allostery through 334 
conformational selection. 335 
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The observed differences in deuterium exchange of overlapping peptides 130-151, 336 
130-169 and 152-169 seemingly do not match, the long peptide 130-169 with a 337 
higher difference than two overlapping peptides added together (130-151 plus 152-338 
169). The increase in relative intensity of the lower exchanging population upon 339 
progesterone binding is suggestive of allosteric effects of progesterone binding at the 340 
N and C-termini. 341 
While X-ray crystallography of apoD did not reveal major conformational changes 342 
upon progesterone binding1, our HDX-MS results show changes in protein dynamics 343 
in the ligand binding pocket as well as in N- and C-terminal regions. Crystallography 344 
is a static snapshot of dynamic regions and changes upon ligand binding may 345 
therefore be masked.29 HDX-MS, in contrast, detects protein structural dynamics and 346 
complements crystallography. In fact, HDX-MS and X-ray crystallography are often 347 
used alongside each other 30,31 and HDX-MS has been shown to detect allosteric 348 
changes in protein dynamics that are not recognised as conformational changes in 349 
crystallography.32 Notably, in the present HDX-MS study, we examined native, fully 350 
glycosylated apoD.       351 
Our experiments showed that progesterone binding leads to a stabilisation of the 352 
apoD pocket as well as of distal regions. Interestingly, HDX-MS studies of AGP have 353 
shown a similar process upon ligand binding. More specifically, binding of 354 
progesterone to AGP induced stabilisation of the β-barrel ligand binding pocket but 355 
not of the adjacent α-helix.18 In contrast, binding of propranolol to AGP resulted in a 356 
stabilisation of both the β-barrel and α-helical regions as we observed in apoD. This 357 
stabilisation effect upon ligand binding could therefore be common to lipocalins.33 In 358 
fact, this feature makes lipocalins an interesting target for protein engineering: By 359 
altering the ligand binding pocket, lipocalins can be designed to bind small target 360 
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ligands as so-called anticalins, that are analogous to antibodies.34 HDX-MS may be a 361 
suitable tool to analyse the anticalin engineering process.  362 
In conclusion, our HDX-MS protocol with modified exchange and quenching 363 
conditions achieved high sequence coverage and is suitable for lipocalins and other 364 
highly stable proteins. Characterising the deuterium exchange behaviour of native, 365 
glycosylated apoD highlighted the rigid and well-ordered structure of apoD. HDX-MS 366 
revealed allosteric and orthosteric changes in apoD upon progesterone binding, 367 
extending our knowledge of apoD structure from X-ray crystallography.1 Allosteric 368 
and orthosteric stabilisation, as seen in apoD, may be a common effect in lipocalins 369 
in response to ligand binding.  370 
 371 
Material and Methods 372 
Chemicals and Reagents 373 
Chemicals for protein purification were biotechnology grade or similar and chemicals 374 
for LC-MS were LC-MS grade or higher. Tris, piperazine, progesterone and glycerol 375 
were sourced from Sigma Aldrich (Castle Hill, NSW, Australia), NaCl from Astral 376 
Scientific (Gymea, NSW, Australia), TCEP from Thermo Fisher Scientific 377 
(Singapore), D2O from Cambridge Isotope Laboratories (Massachusetts, USA), 378 
mono- and di-sodium phosphate from Ajax Finechem and Sigma Aldrich (Castle Hill, 379 
NSW, Australia), GuHCl from Sigma Aldrich (Singapore) and LC-MS mobile phases 380 
from Merck Millipore (USA). 381 
 382 
ApoD purification 383 
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ApoD was purified, as previously described,2 from breast cyst fluid, which was 384 
collected by point of care ultrasound with aspiration of cyst, mixed with protease 385 
inhibitor cocktail (Sigma, 1:100 dilution) and stored at −80°C after removal of 386 
particulate by centrifugation at 23k × g for 20 min. BCF aliquots were thawed on ice 387 
and applied to a GE HiTrap Anion exchange (ANX) Sepharose FF 5 ml column 388 
equilibrated into IEX buffer (20 mM piperazine, pH 5.0). Proteins were eluted with a 389 
0−50% gradient using high salt buffer (20 mM piperazine, 1 M NaCl, pH 5.0) over 4 390 
CV. Fractions containing apoD were identified by Coomassie SDS-PAGE, pooled, 391 
concentrated using Amicon Ultra concentrators with an Ultracel-10 membrane and 392 
buffer exchanged to 50mM phosphate buffer, 150mM NaCl, 3% glycerol, pH 7.4. 393 
Subsequently, apoD was purified in a polishing SEC step using a Superdex 200 394 
16/600 column at a flowrate of 0.75 ml/min, pure apoD fractions were pooled and 395 
concentrated. ApoD concentration were measured a Pierce BCA assay 396 
(ThermoFisher) with bovine serum albumin (BSA) serial dilution as standard curve 397 
according to the manufacturer’s instructions. 398 
 399 
Amide Hydrogen-Deuterium exchange  400 
Deuterated buffer was prepared by vacuum-drying 50 mM phosphate buffer, 150 mM 401 
NaCl, pH 7.4 and reconstituting with 99.9% deuterium oxide. Deuterium exchange 402 
was performed in triplicates on ligand-free apoD and progesterone-bound apoD. 403 
Ligand-free apoD (5 µl, 118.4 µM) or progesterone-bound apoD (4.5 µl apoD, 118.4 404 
µM, pre-incubated with 3x molar excess of progesterone, 0.5 µl, 3 mM, in ethanol) 405 
was mixed with 45 µl deuterated buffer and incubated for 10, 60 and 120 min at 406 
37°C. Deuterium exchange reactions were quenched by addition of pre-chilled 407 
quench solution containing 0.1% trifluoroacetic acid, 3.87 M GuHCl and 147 mM 408 
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TCEP to lower the pHread to 2.5 for a final volume of 100 μl, prior to injection into the 409 
LC-MS system. 410 
 411 
Liquid Chromatography-Mass Spectrometry 412 
The instrument setup and configuration was as previously described.35 The total 413 
volume of quenched deuterium exchange reaction (100 μl) was injected into a 414 
nanoACQUITY UltraPerformance liquid chromatography (UPLC) system (Waters, 415 
Milford, MA). After proteolysis in an immobilised pepsin column (Poroszyme), kept at 416 
12°C, with 0.1% (v/v) formic acid in water at pH ~2.5 at a flow rate of 100 µl/min, the 417 
peptides were trapped in a UPLC VanGuard C18 column for 7 min and then 418 
separated on a ACQUITY UPLC BEH C18 reversed-phase column (Waters), kept at 419 
4°C, and eluted using a water-acetonitrile gradient of 8–40% (v/v) acetonitrile, 0.1% 420 
(v/v) formic acid, pH ~2.5 at a flow-rate of 40 µl/min. Eluted peptides were detected 421 
using a SYNAPT G2-Si mass spectrometer acquiring in MSE mode with continuous 422 
calibration using 200 fmol/μl of Glu-fibrinopeptide B at a flow-rate of 1 μl/min. The 423 
MSE data for undeuterated samples were searched against a database with the input 424 
sequence of human mature apoD (Uniprot P05090, amino acids 21−189) to generate 425 
a list of peptides using ProteinLynx Global SERVER software (PLGS v3.0; Waters). 426 
Peptides identified by PLGS were further filtered and analysed using the semi-427 
automated analysis software DynamX (v3.0; Waters) to obtain the deuteration 428 
profiles of the experimental samples. Relative fractional uptake was calculated by 429 
dividing the absolute uptake by the number of exchangeable amide hydrogens. The 430 




Data analysis and visualisation 433 
Graphs were created using GraphPad Prism 7. Error bars show standard deviation 434 
and are not depicted when smaller than the symbols. A difference in absolute 435 
deuterium uptake of > ±0.5 Da of at least one time point was considered significant. 436 
Structure visualisation was done in PyMOL using the protein structures 2hzr (ligand-437 
free) and 2hzq (progesterone-bound).1 These structures were aligned with 438 
glycosylated models from molecular dynamics simulation.36  439 
 440 
Supplementary Material 441 
Supplementary Figure S1: Mass spectra for peptide 130-169 show bimodal 442 
isotopic distribution.  443 
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Figure captions 556 
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Fig 1. Peptide coverage and overview of protection over the mature apoD 557 
sequence. Pepsin-digested peptides, indicated by bars under the sequence, were 558 
detected in each deuteration experiment. The identified peptides cover 85% of the 559 
mature apoD sequence. Secondary structure elements and disulphide bonds are 560 
marked by red coils (α-helices), yellow arrows (β-strands) and coloured arrows 561 
(disulphide bonds). Asn-45 and Asn-78, which carry the glycosylations, are coloured 562 
in orange and the redox-active Met-93 in light blue. Each peptide was colour-coded 563 
according to the heat map of relative fractional deuterium exchange after 120 min 564 
(colour-bar on the right). Overall, the N-terminus was found to be more protected 565 
than the C-terminus. 566 
 567 
Fig 2. Relative fractional deuterium exchange of the apo-form of apoD reveals 568 
differences in exchange and dynamics. A) Relative fractional exchange of ligand-569 
free apoD was calculated by normalising the absolute deuterium exchange after 10, 570 
60 and 120 min to exchangeable amides per peptide. Colour-coded peptides show 571 
different behaviours in deuterium exchange extent or dynamics. The graph depicts 572 
means of triplicates, error bars show standard deviation and are not depicted when 573 
smaller than the symbols. Asterisks denote peptides showing bimodal exchange 574 
profiles. B-D) Absolute deuterium exchange over time of marked peptides showed 575 
low deuterium exchange (102-111), high deuterium exchange (130-143), low 576 
dynamics (102-111) and high dynamics (49-61). Graphs show means of triplicates, 577 
error bars show standard deviation and are not depicted when smaller than the 578 
symbols. Y-axes are normalised to half of the number of exchangeable hydrogens. 579 
The spectra of undeuterated peptides and after 10 and 120 min of deuteration are 580 
shown below indicating the centroid shift. E) Mapped peptides 102-111 (blue, low 581 
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exchange and low dynamics), 130-143 (orange, high exchange) and 49-61 (green, 582 
high dynamics) are mapped onto the crystal structure of apoD.  583 
 584 
Fig 3. Overview of exchange and dynamics over the apoD structure. A) Relative 585 
fraction deuterium exchange after 120 min of non-overlapping peptides in putty 586 
representation and colour-coded. B) Areas with low (area 2, magenta) and high 587 
dynamics (areas 1 and 3, green) as identified in Figure 2A.  588 
 589 
Fig 4. Binding of progesterone induces significant orthosteric and allosteric 590 
changes in deuterium exchange of apoD. A) Difference plot generated by 591 
subtracting the absolute deuterium exchange of ligand-free apoD from progesterone-592 
bound apoD. Differences > ±0.5 Da are considered significant and were found in nine 593 
peptides (marked red: Increased exchange, blue: decreased exchange upon 594 
progesterone binding). Asterisks denote peptides showing bimodal exchange profiles 595 
in both the apo-form and in the presence of progesterone. B) Absolute deuterium 596 
exchange over time of nine peptides showing significant changes upon progesterone 597 
binding. The graphs show means of triplicates. Y-axes are normalised to half of the 598 
number of exchangeable hydrogens. C) Significant orthosteric changes in apoD upon 599 
progesterone binding. D) Zoom of the ligand binding pocket. Asn-58 is located in 600 
peptide 49-61 which shows increased deuterium exchange upon progesterone 601 
binding. Met-93 and Phe-98 are located in peptides which show decreased 602 
deuterium exchange upon progesterone binding. E) Significant allosteric changes in 603 
apoD upon progesterone binding. F) Hydrogen bond network between progesterone, 604 




Fig S1: Mass spectra for peptide 130-169 show bimodal isotopic distribution. 607 
Peptide 130-169 shows a bimodal isotopic distribution indicating at least two 608 
conformational isomers. Progesterone binding shifts the distribution towards the 609 
lower exchanging conformation. 610 
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